About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Treatment Considerations in MDS from ASCO/EHA 2022
Treatment Considerations in MDS from ASCO/EHA 2022
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
T, NK, and Macrophage-Based Therapies in AML
By
SOHO Italy 1st Clinical and Biological School of CAR-T
FEATURING
Naval Daver
By
SOHO Italy 1st Clinical and Biological School of CAR-T
FEATURING
Naval Daver
194 views
May 2, 2022
0 Comments
Login to view comments.
Click here to Login
Treatment Considerations in MDS from ASCO/EHA 2022
24:29
MDS Foundation
Immunotherapy Strategies in MDS
Feat.
S. Gill
24:49
MDS Foundation
The Evolving Use of Immune Checkpoint Blockade in Management of MDS
Feat.
A. Zeidan
22:43
Penn Medicine Abramson Cancer Center
Highlights in the Prognostication of MDS This Year
Feat.
S. McCurdy
20:10
Rush University Medical Center
Novel Agents for MDS
Feat.
S. Dinner
04:48
EHA 2022 Conference Coverage
EHA 2022 Magrolimab in Combination With Azacitidine for Untreated Hi…
Feat.
D. Sallman
10:02
Gautham Borthakur
Anti-CD47 Therapy in MDS
15:31
Yale Cancer Center
The Importance of the TP53 Evaluation in the Management of HR-MDS
Feat.
R. Shallis
09:58
Penn Medicine Abramson Cancer Center
EHA and ASCO 2022 Penn Medicine Updates on AML and MDS
Feat.
K. Pratz
20:03
SOHO Italy 1st Clinical and Biological School of CAR-T
T, NK, and Macrophage-Based Therapies in AML
Feat.
N. Daver
39:34
MDS Foundation
Making Heads and Tails of NGS Printouts and Their Role in MDS
Feat.
B. Ebert
16:58
MDS Foundation
Mechanisms and Predictors of Drug Resistance in HR-MDS: Intolerance …
Feat.
M. Sekeres
27:27
Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies
2022 State of the Art Frontline Management of the HR-MDS
Feat.
R. Komrokji
06:24
EHA 2022 Conference Coverage
EHA 2022 CD47 Targeting in HR-MDS: Surveying Clinical Data for Magro…
Feat.
D. Sallman
30
EHA 2022 Conference Coverage
Lecture Summary - EHA 2022 CD47 Targeting in HR-MDS: Surveying Clini…
Feat.
D. Sallman
35:36
MDS Foundation
Optimizing Transfusion Support for Patients With MDS
Feat.
Y. Lin